R M E Richards

1.3k total citations
61 papers, 1.1k citations indexed

About

R M E Richards is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, R M E Richards has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Organic Chemistry and 18 papers in Pharmacology. Recurrent topics in R M E Richards's work include Antimicrobial agents and applications (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). R M E Richards is often cited by papers focused on Antimicrobial agents and applications (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). R M E Richards collaborates with scholars based in United Kingdom, United States and Malaysia. R M E Richards's co-authors include David G. Durham, Michael R. Brown, David Stead, D. Xing, Dorothy Xing, Narumol Jarernsiripornkul, Janet Krska, Robert B. Taylor, H. A. Odelola and Xiaojun Liu and has published in prestigious journals such as Nature, The Lancet and International Journal of Pharmaceutics.

In The Last Decade

R M E Richards

58 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R M E Richards United Kingdom 19 319 248 205 134 123 61 1.1k
Alfred Tonelli United States 12 477 1.5× 434 1.8× 106 0.5× 176 1.3× 64 0.5× 25 2.0k
Sujata G. Dastidar India 25 829 2.6× 317 1.3× 370 1.8× 208 1.6× 265 2.2× 62 1.6k
Bernard J. Abbott United States 22 854 2.7× 394 1.6× 139 0.7× 88 0.7× 49 0.4× 41 1.5k
Teresa Dalla Costa Brazil 27 564 1.8× 703 2.8× 212 1.0× 199 1.5× 228 1.9× 149 2.4k
D. T. W. CHU United States 15 404 1.3× 399 1.6× 214 1.0× 42 0.3× 237 1.9× 27 896
Valéria Pereira de Sousa Brazil 26 343 1.1× 144 0.6× 182 0.9× 281 2.1× 67 0.5× 120 2.0k
Jiřı́ Klimeš Czechia 22 282 0.9× 350 1.4× 212 1.0× 159 1.2× 255 2.1× 122 1.7k
Limin He China 20 269 0.8× 208 0.8× 125 0.6× 324 2.4× 61 0.5× 83 1.3k
Thomas A. Robertson Australia 22 396 1.2× 553 2.2× 157 0.8× 143 1.1× 232 1.9× 45 2.3k
Chandan Shivamallu India 24 443 1.4× 146 0.6× 363 1.8× 172 1.3× 106 0.9× 164 2.1k

Countries citing papers authored by R M E Richards

Since Specialization
Citations

This map shows the geographic impact of R M E Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R M E Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R M E Richards more than expected).

Fields of papers citing papers by R M E Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R M E Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R M E Richards. The network helps show where R M E Richards may publish in the future.

Co-authorship network of co-authors of R M E Richards

This figure shows the co-authorship network connecting the top 25 collaborators of R M E Richards. A scholar is included among the top collaborators of R M E Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R M E Richards. R M E Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jarernsiripornkul, Narumol, et al.. (2003). Patient reporting of adverse drug reactions: useful information for pain management?. European Journal of Pain. 7(3). 219–224. 26 indexed citations
2.
Durham, David G., et al.. (2000). Baicalin Synergy with β-Lactam Antibiotics Against Methicillin-resistant Staphylococcus aureus and Other β-Lactam-resistant Strains of S. aureus. Journal of Pharmacy and Pharmacology. 52(3). 361–366. 124 indexed citations
3.
Stead, David & R M E Richards. (1997). Sensitive high-performance liquid chromatographic assay for aminoglycosides in biological matrices enables the direct estimation of bacterial drug uptake. Journal of Chromatography B Biomedical Sciences and Applications. 693(2). 415–421. 39 indexed citations
4.
Richards, R M E, et al.. (1996). Brodimoprim synergy against Enterococcus faecalis evaluated in vitro. Journal of Antimicrobial Chemotherapy. 38(1). 27–37. 3 indexed citations
5.
Richards, R M E, et al.. (1996). The Effect of Formulation on the Antimicrobial Activity of Cetylpyridinium Chloride in Candy Based Lozenges. Pharmaceutical Research. 13(4). 583–587. 5 indexed citations
7.
Richards, R M E, D. Xing, & Te Piao King. (1995). Activity of p ‐aminobenzoic acid compared with other organic acids against selected bacteria. Journal of Applied Bacteriology. 78(3). 209–215. 43 indexed citations
8.
Durham, David G., Xiaojun Liu, & R M E Richards. (1994). A triterpene from Rubus pinfaensis. Phytochemistry. 36(6). 1469–1472. 41 indexed citations
9.
Richards, R M E & D. Xing. (1994). Capillary zone electrophoresis assay of the uridine diphosphate N-acetylmuramyl peptide precursors and the disaccharide pentapeptide derivative of bacterial cell wall peptidoglycan. Journal of Pharmaceutical and Biomedical Analysis. 12(3). 301–305. 7 indexed citations
10.
Richards, R M E & D. Xing. (1994). Determination of thymidine, uracil and p-aminobenzoic acid in bacteriological cultures by capillary zone electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 12(9). 1063–1068. 8 indexed citations
11.
Richards, R M E & Dorothy Xing. (1993). Investigation of Synergism between Combinations of Ciprofloxacin, Polymyxin, Sulphadiazine andp-Aminobenzoic acid. Journal of Pharmacy and Pharmacology. 45(3). 171–175. 19 indexed citations
12.
Richards, R M E, et al.. (1993). An electronmicroscope study of the effect of sulphadiazine and trimethoprim on Enterobacter cloacae. Journal of Medical Microbiology. 38(1). 64–68. 16 indexed citations
13.
Taylor, Robert B., R M E Richards, & Juan Xing. (1992). Simultaneous determination of some antibacterial drugs in Isosensitest broth using high-performance liquid chromatography with solid-phase extraction. The Analyst. 117(9). 1425–1425. 9 indexed citations
14.
Richards, R M E, Robert B. Taylor, & Dorothy Xing. (1991). An Evaluation of the Antibacterial Activities of Combinations of Sulfonamides, Trimethoprim, Dibromopropamidine, and Silver Nitrate Compared with Their Uptakes by Selected Bacteria. Journal of Pharmaceutical Sciences. 80(9). 861–867. 41 indexed citations
15.
16.
Richards, R M E, et al.. (1976). Electron Microscope Study of Effect of Benzalkonium Chloride and Edetate Disodium on Cell Envelope of Pseudomonas aeruginosa. Journal of Pharmaceutical Sciences. 65(1). 76–80. 52 indexed citations
17.
Richards, R M E. (1975). The antipseudomonal activity of contact lens solutions. Journal of Pharmacy and Pharmacology. 27(5). 381–382. 6 indexed citations
18.
Richards, R M E, et al.. (1972). Letters to the Editor: Interaction between sodium metabisulphite and PMN. Journal of Pharmacy and Pharmacology. 24(12). 999–1000. 5 indexed citations
19.
Richards, R M E. (1971). Inactivation of resistant Pseudomonas aeruginosa by antibacterial combinations. Journal of Pharmacy and Pharmacology. 23(Supplement_1). 136S–140S. 7 indexed citations
20.
Richards, R M E & Michael R. Brown. (1964). Resistance of Pseudomonas aeruginosa to chemical inactivation. Journal of Pharmacy and Pharmacology. 16(5). 360–361. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026